Response to Comment on Hillis et al: The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295–303

Graham S. Hillis, Paul Welsh, John Chalmers, Mark Woodward, Naveed Sattar

Research output: Contribution to journalComment/debate

Abstract

We are grateful to Neuhold et al. (1) for their interest in our article (2) and agree
with their insightful comments. They highlight an interesting juxtaposition in
the field of preventative medicine. While there is increasing disquiet being
aired by many regarding the overdiagnosis and overtreatment of some conditions in developed countries, at the same time guidelines for the prevention of cardiovascular disease in the general populations of these countries are being
considerably broadened.
Original languageEnglish
Pages (from-to)e154-e154
Number of pages1
JournalDiabetes Care
Volume37
Issue number6
DOIs
Publication statusPublished - Jun 2014
Externally publishedYes

Bibliographical note

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

Keywords

  • type 2 diabetes
  • blood pressure
  • NT-proBNP
  • high-sensitivity troponin

Fingerprint Dive into the research topics of 'Response to Comment on Hillis et al: The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295–303'. Together they form a unique fingerprint.

  • Cite this